Arkolith/Insider Trading/PMVP/Form 4

Gallagher Carol Giltner

DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Jun 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 4, 2026Grant(A)42K—$042K
Jun 4, 2026Gift(G)42K—$00
Jun 4, 2026Gift(G)42K—$042K

Transaction Codes

A
Grant / award
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001329959-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML